HRPT2-related familial isolated hyperparathyroidism: Could molecular studies direct the surgical approach?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1211-1220

  Silveira, Leticia G ^a   Dias, Eduardo P ^a,b   Marinho, Bruna C G ^a,b   Gomez, Ricardo S ^a   De Marco, Luiz ^a,b   Sarquis, Marta S ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b HOSPITAL FELÍCIO ROCHO   (Brazil)

Author keywords

FIHP; HRPT2; Jaw tumor; Parafibromin; Parathyroid; Surgery

Indexed keywords

EID: 58849137885     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000800003     Document Type: Article

References (44)

1. Miedlich S, Krohn K, Paschke R. Update on genetic and clinical aspects of primary hyperparathyroidism. Clin Endocrinol. 2003;59(5):539-54.
2. Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN et. al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine. 2002;81(1):1-26.
3. Warner JV, Nyholt DR, Busfield F, Epstein M, Burgess J, Stranks S et al. Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.314. J Med Genet. 2006;43(3):e12.
4. Evans DB, Rich TA, Cote GJ. Surgical management of familial hyperparathyroidism. Ann Surg Oncol. 2007;14(2):1525-27.
5. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet. 1995;56(4):944-50.
6. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32(4):676-80,
7. Jackson CE, Norum RA, Boyd SB, Talpos GB, Wilson SD, Taggart RT, et al. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery. 1990;108(6):1006-12.
8. Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH. Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg. 1997;21(1):22-8.
9. Teh BT, Esapa CT, Houlston R, Grandell U, Farnebo F, Nordenskjold M, et al. A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet. 1998;63(5):1544-9.
10. Honda M, Tsukada T, Tanaka H, Maruyama K, Yamaguchi K, Obara T, et al. A novel mutation of the MEN 1 gene in a Japanese kindred with familial isolated hyperparathyroidism. Eur J Endocrinol. 2000;142(2):138-43.
11. Kassem M, Kruse TA, Wong FK, Larsson C, Teh BT. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab. 2000;85(1):165-7.
12. Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F, et al. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol. 2002;56(4):457-64.
13. Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, et al. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol. 2006;65(1):9-16.
14. Teh BT, Farnebo F, Twigg S, Hoog A, Kytola S, Korpi-Hyovalti E, et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab. 1998;83(6):2114-20.
15. Haven CJ, Wong FK, van Dam EW, van der Juijt R, van Asperen C, Jansen J, et al. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab. 2000;85(4):1449-54.
16. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et. al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet. 2003;40(1):657-63.
17. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349 (18):1722-9.
18. Krebs LJ, Shattuck TM, Arnold A. HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab. 2005;90(9):5015-7.
19. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, et al. The parafibromin tumor suppressor protein is part of a human pafl complex. Mol Cell Biol. 2005;25(2):612-20.
20. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2 regulates cyclin D1/PRAD1 expression. Oncogene. 2005;24(7):1272-6.
21. Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, et al. Loss of parafibronnin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res. 2004;10 (19):6629-37.
22. Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, et al. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer. 2006;13(2):509-23.
23. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343(25):1863-75.
24. Boom R, Sol C, Beld M, Weel J, Goudsmit J, Wertheim-van Dillen P. Improved silica-guanidinium thiocyanate DNA isolation procedure based on selective binding of bovine alphacasein to silica particles J Clin Microbiol. 1999;37(3):615-9.
25. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab. 2004;89(11):5583-91.
26. Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res. 2004;10 f19):6629-37.
27. Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery. 2007;142(3):398-404.
28. Shabtai M, Ben-Haim M, Muntz Y, Vered I, Rosin D, Kuriansky J, et al. 140 consecutive cases of minimally invasive, radioguided parathyroidectomy: lessons learned and long-term results. Surg Endosc. 2003;17(5):688-91.
29. Sarquis MS, Silveira LG, Pimenta FJ Dias EP, Teh BT, Friedman E et al. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery. 2008;143(5):630-40.
30. Evans DB, Rich TA, Cote GJ. Surgical management of familial hyperparathyroidism. Ann Surg Oncol. 2007;14(5):1525-7.
31. lacobone M, Barzon L, Porzionato A, Masi G, Macchi V, Marino F, et al. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism. Surgery. 2007;142(6):984-91.
32. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med. 2005;257(1):27-37.
33. Pannett AA, Kennedy AM, Turner JJ Forbes SA, Cavaco BM, Bassett JH, et al. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol. 2003;58(5):639-46.
34. Guarnieri V, Scillitani A, Muscarella LA, Battista C, Bonfitto N, Bisceglia M, et al. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab. 2006;91(8):2861-3.
35. VanderWalde LH, Haigh PI. Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol. 2006;7(4):326-32.
36. Scillitani A, Guarnieri V, Bisceglia M, Bonfitoo N, Cetani F, Marcocci C, et al. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Letter to the Editor - Surgery (ahead of publication)
37. Cetani F, Pardi E, Ambrogini E, Viacava P, Borsari S, Lemmi M, et al. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer. 2007;14(2):493-9.
38. Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol. 2007;14(2):739-43.
39. Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, et. al. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Min Res. 2006;21(10):1666-71.
40. Moon SD, Park JH, Kim EM, Kim JH, Han JH, Yoo SJ, et al. A novel IVS2-IGOA mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab. 2005;90(2):878-83.
41. Villablanca A, Calender A, Forsberg L, Hoog A, Cheng JD, Petillo D, et al. Germline and de novo mutations in the HRPT2 tumor suppressor gene in familial isolated hyperparathyroidism (FIHP) J Med Genetics. 2004;41:e32.
42. Carneiro DM, Irvin GL, Inabnet WB. Limited versus radical parathyreoidectomy in familial isolated primary hyperparathyroidism. Surgery. 2002;132(6):1050-5.
43. Katz SC, Wang GJ, Kramer EL, Roses DF. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surg. 2003;69(2):170-5.
44. Knudson AG Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985;45(4):1437-43.